company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3062919000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,108698000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3171617000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,335192000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,335192000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2836425000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,776103000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1009336000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,257495000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,14079000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-360000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2056653000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,779772000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,72396000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,72396000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,852168000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,272423000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,579745000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,579745000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-58427000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,638172000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,315836000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.02
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,320171000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.99
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,315900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2007.0,FY,2007-01-01,2007-12-31,2010-02-09 17:21:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.02
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3967889000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,129618000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4097507000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,401989000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,401989000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3695518000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,925305000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1097058000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,332745000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,136041000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-9242000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2481907000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1213611000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-57728000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-57728000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1155883000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,365776000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,790107000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,790107000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6940000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,783167000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,292332000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.67
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,294984000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.65
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,293300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,FY,2008-01-01,2008-12-31,2010-02-09 17:21:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.67
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1057239000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,35725000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1092964000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,107493000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,107493000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,985471000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,232824000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,268800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,94464000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,43533000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,639621000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,345850000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-23713000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-23713000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,322137000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,114337000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,207800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,207800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1012000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,206788000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,291408000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.71
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,293921000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.7
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,291300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q3,2008-07-01,2008-09-30,2009-10-21 16:58:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.71
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,963308000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,30136000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,993444000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,92401000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,92401000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,901043000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,245689000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,252259000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,72869000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,33429000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,604246000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,296797000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4018000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4018000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,292779000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,84706000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,208073000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,208073000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1445000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,206628000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,290356000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.71
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,293476000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.7
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,291000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2008.0,Q2,2008-04-01,2008-06-30,2009-07-16 19:50:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.71
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1083429000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,43628000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1127057000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,99700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,99700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1027357000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,241620000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,283082000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,55982000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,63296000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,643980000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,383377000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6366000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6366000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,389743000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,83747000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,305996000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,305996000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,359000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,305637000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,287356000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.07
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,289476000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.07
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,287900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q4,2009-10-01,2009-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.07
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4247804000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,129544000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4377348000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,382104000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,382104000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3995244000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,911034000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1283068000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,289811000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,215904000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2699817000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1295427000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,37252000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,37252000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1332679000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,355617000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,977062000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,977062000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6930000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,970132000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,287356000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.37
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,289476000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.35
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,287900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,FY,2009-01-01,2009-12-31,2012-02-03 17:19:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.37
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1085608000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,34910000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1120518000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,93486000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,93486000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1027032000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,226755000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,304055000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,51347000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,60697000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,642854000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,384178000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,9360000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,9360000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,393538000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,113936000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,279602000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,279602000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1939000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,277663000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,288917000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.96
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,291037000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.95
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,289200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3,2009-07-01,2009-09-30,2009-10-21 16:58:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.96
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3164375000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,85916000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3250291000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,282404000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,282404000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2967887000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,669414000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,999986000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,233829000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,152608000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2055837000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,912050000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,30886000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,30886000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,942936000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,271870000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,671066000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,671066000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6571000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,664495000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,288917000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.3
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,291037000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.28
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,289200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q3YTD,2009-01-01,2009-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.3
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1066540000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,26749000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1093289000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,90721000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,90721000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1002568000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,220829000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,416453000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,93234000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,49138000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,779654000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,222914000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,14680000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,14680000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,237594000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,92709000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,144885000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,144885000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2040000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,142845000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,288615000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.49
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,290359000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.49
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,291500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2,2009-04-01,2009-06-30,2009-07-16 19:50:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.49
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2078767000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,51006000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2129773000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,188918000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,188918000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1940855000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,442659000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,695931000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,182482000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,91911000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1412983000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,527872000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,21526000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,21526000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,549398000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,157934000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,391464000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,391464000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,4632000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,386832000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,288615000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.34
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,290359000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.33
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,291500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q2YTD,2009-01-01,2009-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.34
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1012227000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,24257000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1036484000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,98197000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,98197000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,938287000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,221830000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,279478000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,89248000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,42773000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,633329000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,304958000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6846000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6846000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,311804000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,65225000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,246579000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,246579000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2592000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,243987000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,287703000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.85
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,289744000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.84
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,287000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2009.0,Q1,2009-01-01,2009-03-31,2010-04-20 15:31:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.85
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1167715000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,51357000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1219072000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,100304000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,100304000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1118768000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,276394000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,535821000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,53360000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-177145000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,75153000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,763583000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,355185000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4664000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4664000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,350521000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,78769000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,271752000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,271752000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,31474000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,240278000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,252307000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.99
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,254867000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.97
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,252600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.99
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4547300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,169123000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4716423000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,400262000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,400262000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4316161000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1031540000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1493580000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,208928000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,258071000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,75153000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3067272000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1248889000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-18983000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18983000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1229906000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,331333000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,898573000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,898573000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-106700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1005273000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,252307000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.98
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,254867000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.94
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,252600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,FY,2010-01-01,2010-12-31,2013-02-05 06:42:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.98
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1134831000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,40958000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1175789000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,95918000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,95918000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1079871000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,244160000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,319054000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,53531000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,268991000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,885736000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,194135000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6945000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6945000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,187190000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,75011000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,112179000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,112179000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-141936000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,254115000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,239864000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.06
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,242313000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.05
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,239700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3,2010-07-01,2010-09-30,2010-10-26 14:10:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.06
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3379585000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,117766000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3497351000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,299958000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,299958000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3197393000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,755146000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,957759000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,155568000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,435216000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2303689000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,893704000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-14319000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14319000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,879385000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,252564000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,626821000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,626821000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-138174000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,764995000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,239864000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.99
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,242313000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.97
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,239700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.99
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4463014000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,161394000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4624408000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,399658000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,399658000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4224750000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,996766000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1240841000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,211550000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,498512000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2947669000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1277081000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7953000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7953000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1269128000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,336311000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,932817000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,932817000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-137815000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1070632000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,239864000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.06
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,242313000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.04
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,239700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q3TTM,2009-10-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.06
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1165606000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,47096000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1212702000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,106985000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,106985000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1105717000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,262322000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,331675000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,53148000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,62692000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,709837000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,395880000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1012000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1012000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,396892000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,102243000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,294649000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,294649000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1211000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,293438000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,259938000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.13
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,261658000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.12
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,259700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2,2010-04-01,2010-06-30,2010-07-20 16:23:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.13
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2244754000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,76808000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2321562000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,204040000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,204040000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2117522000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,510986000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,638705000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,102037000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,166225000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1417953000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,699569000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7374000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7374000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,692195000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,177553000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,514642000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,514642000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,3762000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,510880000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,259938000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.93
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,261658000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.92
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,259700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.93
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4413791000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,155346000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4569137000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,397226000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,397226000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4171911000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,979361000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1225842000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,209366000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,290218000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2704787000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1467124000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8352000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8352000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1475476000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,375236000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1100240000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1100240000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6060000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1094180000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,259938000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.96
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,261658000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.94
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,259700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q2TTM,2009-07-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.96
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1079148000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,29712000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1108860000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,97055000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,97055000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1011805000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,248664000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,307030000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,48889000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,103533000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,708116000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,303689000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-8386000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8386000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,295303000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,75310000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,219993000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,219993000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2551000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,217442000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,269922000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.8
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,272703000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.8
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,271800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1,2010-01-01,2010-03-31,2010-04-20 15:31:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.8
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4314725000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,134999000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4449724000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,380962000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,380962000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4068762000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,937868000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1310620000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,249452000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,276664000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2774604000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1294158000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,22020000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,22020000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1316178000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,365702000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,950476000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,950476000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6889000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,943587000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,269922000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.32
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,272703000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.31
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,271800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2010.0,Q1TTM,2009-04-01,2010-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.32
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1254099000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,72612000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1326711000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,139637000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,139637000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1187074000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,283918000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,338934000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,50867000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,49162000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,19026000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,36065000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,777972000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,409102000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3973000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3973000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,405129000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,104920000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,300209000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,300209000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-28000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,300237000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,242395000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.23
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,245033000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.23
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,242500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.23
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4832714000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,215920000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5048634000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,466780000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,466780000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4581854000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1056133000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1219602000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,208566000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,317771000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,19026000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,36065000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2857163000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1724691000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-13477000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13477000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1711214000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,444528000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1266686000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1266686000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,32258000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1234428000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,242395000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.09
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,245033000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.04
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,242500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,FY,2011-01-01,2011-12-31,2014-02-06 17:28:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.09
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1242228000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,67706000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1309934000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,123527000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,123527000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1186407000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,261398000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,301391000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,49347000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,85778000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,697914000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,488493000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7727000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7727000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,480766000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,127104000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,353662000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,353662000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1836000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,351826000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,242883000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.45
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,245366000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.43
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,242600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3,2011-07-01,2011-09-30,2011-10-28 16:14:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.45
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3578615000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,143308000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3721923000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,327143000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,327143000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3394780000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,772215000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,880668000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,157699000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,268609000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2079191000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1315589000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9504000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9504000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1306085000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,339608000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,966477000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,966477000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,32286000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,934191000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,242883000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.86
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,245366000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.81
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,242600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.86
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4746330000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,194665000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4940995000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,427447000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,427447000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4513548000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1048609000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1416489000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,211059000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,91464000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,75153000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2842774000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1670774000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-14168000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14168000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1656606000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,418377000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1238229000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1238229000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,63760000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1174469000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,242883000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.85
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,245366000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.78
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,242600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.85
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1173161000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,35486000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1208647000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,100503000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,100503000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1108144000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,266301000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,285644000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,55136000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,90250000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,697331000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,410813000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11728000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11728000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,399085000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,95036000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,304049000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,304049000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,16015000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,288034000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,242375000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.19
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,244966000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.18
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,242000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2,2011-04-01,2011-06-30,2011-07-26 16:12:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.19
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2336387000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,75602000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2411989000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,203616000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,203616000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2208373000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,510817000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,579277000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,108352000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,182831000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1381277000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,827096000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1777000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1777000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,825319000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,212504000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,612815000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,612815000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,30450000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,582365000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,242375000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.41
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,244966000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.38
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,242000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.41
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4638933000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,167917000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4806850000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,399838000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,399838000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4407012000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1031371000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1434152000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,215243000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,274677000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,75153000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3030596000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1376416000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-13386000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13386000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1363030000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,366284000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,996746000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,996746000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-80012000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1076758000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,242375000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.46
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,244966000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.4
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,242000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.46
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1163226000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,40116000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1203342000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,103113000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,103113000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1100229000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,244516000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,293633000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,53216000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,92581000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,683946000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,416283000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,9951000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,9951000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,426234000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,117468000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,308766000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,308766000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,14435000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,294331000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,241536000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.22
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,244551000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.2
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,241300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1,2011-01-01,2011-03-31,2011-04-21 09:27:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.22
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4631378000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,179527000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4810905000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,406320000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,406320000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4404585000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1027392000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1480183000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,213255000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,247119000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,75153000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3043102000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1361483000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-646000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-646000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1360837000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,373491000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,987346000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,987346000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-94816000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1082162000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,241536000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.4
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,244551000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.34
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,241300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.4
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-65326000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,62317000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,-3009000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,133827000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,133827000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-136836000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,375978000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,345181000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,50948000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1344145000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1139000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-11443000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-582342000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,445506000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-14290000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14290000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,431216000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,136341000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-3260000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,291615000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,292126000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,292126000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,237938000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.24
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,239740000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.23
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,237900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.24
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5303997000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,212464000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5516461000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,545494000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,545494000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4970967000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1277465000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1334919000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,202204000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,317895000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2225000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-19590000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3115118000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1855849000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-744000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-744000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1855105000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,470554000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-4518000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1380033000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1380033000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1380033000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,237938000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.8
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,239740000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.76
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,237900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,FY,2012-01-01,2012-12-31,2015-02-04 16:39:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.8
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1326902000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,58652000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1385554000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,139358000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,139358000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1246196000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,299631000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,304217000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,53013000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,75545000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,803000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-22263000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,710946000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,535250000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4548000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4548000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,530702000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,131044000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-1258000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,398400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,398400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,398400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,236474000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.68
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,238125000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.67
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,237100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3,2012-07-01,2012-09-30,2012-10-25 16:15:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.68
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5369323000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,150147000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5519470000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,411667000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,411667000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5107803000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,901487000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,989738000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,151256000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1662040000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1086000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-8147000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3697460000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1410343000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,13546000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,13546000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1423889000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,334213000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-1258000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1088418000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1087907000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1087907000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,236474000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.56
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,238125000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.53
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,237100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.56
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6623422000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,222759000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6846181000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,551304000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,551304000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6294877000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1185405000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1328672000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,202123000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1711202000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,20112000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,27918000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4475432000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1819445000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,9573000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,9573000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1829018000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,439133000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-1258000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1388627000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1388116000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-28000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1388144000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,236474000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.79
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,238125000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.76
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,237100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.79
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2782381000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,59521000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2841902000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,139112000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,139112000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2702790000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,301767000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,329559000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,52282000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1500601000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,12858000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2197067000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,505723000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2950000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2950000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,508673000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,121021000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,387652000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,387141000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,295000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,386846000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,238988000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.62
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,240622000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.61
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,238800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2,2012-04-01,2012-06-30,2012-07-24 15:43:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.62
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4042421000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,91495000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4133916000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,272309000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,272309000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3861607000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,601856000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,685521000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,98243000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1586495000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,283000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,14116000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2986514000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,875093000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,18094000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,18094000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,893187000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,203169000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,690018000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,689507000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,689507000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,238988000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.88
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,240622000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.86
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,238800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.88
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6538748000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,231813000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6770561000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,535473000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,535473000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6235088000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1147172000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1325846000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,198457000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1721435000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,19309000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,50181000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4462400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1772688000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6394000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6394000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1779082000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,435193000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1343889000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1343378000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1808000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1341570000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,238988000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.56
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,240622000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.52
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,238800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.56
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1260040000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,31974000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1292014000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,133197000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,133197000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1158817000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,300089000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,355962000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,45961000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,85894000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,283000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1258000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,789447000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,369370000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,15144000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,15144000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,384514000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,82148000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,302366000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,302366000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-295000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,302661000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,239754000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.26
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,241828000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.25
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,240200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1,2012-01-01,2012-03-31,2012-05-01 16:22:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.26
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4929528000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,207778000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5137306000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,496864000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,496864000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4640442000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1111706000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1281931000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,201311000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,311084000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,19309000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,37323000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2962664000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1677778000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-8284000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8284000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1669494000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,409208000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1260286000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1260286000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,17528000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1242758000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,239754000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.13
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,241828000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.09
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,240200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.13
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1876496000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,89354000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1965850000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,258553000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,258553000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1707297000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,522857000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,422233000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,109424000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-5143000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1049371000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,657926000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5405000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5405000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,652521000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,190261000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-4954000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,457306000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,457306000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,457306000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,236919000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.93
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,238308000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.91
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,236900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.93
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6668348000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,263851000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6932199000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,857726000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,857726000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6074473000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1712051000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1444053000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,342948000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,85357000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-25445000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3558964000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2515509000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-34930000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-34930000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2480579000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,601014000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-17224000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1862341000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1862341000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1862341000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,236919000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,7.86
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,238308000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,7.81
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,236900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,FY,2013-01-01,2013-12-31,2015-02-04 16:39:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.86
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1756764000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,71016000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1827780000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,234696000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,234696000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1593084000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,405584000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,410017000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,99998000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-7046000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,908553000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,684531000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4640000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4640000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,679891000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,186105000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-6170000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,487616000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,487616000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,487616000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,237070000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.06
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,238349000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.05
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,236700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3,2013-07-01,2013-09-30,2013-10-28 14:13:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.06
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4791852000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,174497000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4966349000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,599173000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,599173000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4367176000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1189194000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1021820000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,233524000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,85357000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-20302000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2509593000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1857583000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-29525000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-29525000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1828058000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,410753000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-12270000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1405035000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1405035000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1405035000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,237070000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.93
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,238349000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.9
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,236700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.93
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4726526000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,236814000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4963340000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,733000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,733000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4230340000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1565172000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1367001000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,284472000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1258788000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1139000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-31745000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1927251000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2303089000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-43815000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-43815000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2259274000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,547094000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-15530000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1696650000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1697161000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1697161000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,237070000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,7.17
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,238349000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,7.13
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,236700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.17
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1674703000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,48770000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1723473000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,230728000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,230728000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1492745000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,431012000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,327463000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,82225000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-10482000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,830218000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,662527000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10428000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10428000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,652099000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,159140000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-2289000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,490670000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,490670000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,490670000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,237484000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.07
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,238743000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.06
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,237000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2,2013-04-01,2013-06-30,2013-07-25 16:43:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.07
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3035088000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,103481000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3138569000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,364477000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,364477000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2774092000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,783610000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,611803000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,133526000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,85357000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-13256000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1601040000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1173052000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-24885000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-24885000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1148167000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,224648000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-6100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,917419000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,917419000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,917419000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,237484000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.87
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,238743000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.85
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,237000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.87
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4296664000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,224450000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4521114000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,637662000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,637662000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3883452000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1459219000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1261201000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,237487000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1183243000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1942000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-46962000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1729644000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2153808000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-43723000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-43723000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2110085000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,492033000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-10618000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1607434000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1607945000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1607945000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,237484000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.79
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,238743000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.75
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,237000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.79
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1360385000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,54711000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1415096000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,133749000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,133749000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1281347000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,352598000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,284340000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,51301000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,85357000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-2774000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,770822000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,510525000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-14457000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14457000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,496068000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,65508000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-3811000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,426749000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,426749000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,426749000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,236837000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.8
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,238304000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.79
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,237100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1,2013-01-01,2013-03-31,2013-04-25 16:01:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.8
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5404342000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,235201000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5639543000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,546046000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,546046000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5093497000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1329974000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1263297000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,207544000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,317358000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1942000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-23622000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3096493000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1997004000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-30345000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-30345000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1966659000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,453914000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-8329000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1504416000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1504416000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,295000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1504121000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,236837000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.34
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,238304000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.3
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,237100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.34
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9398800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,304500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9703300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1171000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1171000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8532300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2232300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1893400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,489800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-55700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4559800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3972400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-25800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-25800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3946600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,989900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-15100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2941600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2941600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2934800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,236400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,12.42
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,237200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,12.37
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,236300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,FY,2014-01-01,2014-12-31,2017-02-02 16:24:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,12.42
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2591518000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,49133000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2640651000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,297229000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,297229000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2343422000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,573568000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,500069000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,107285000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,2651000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1183573000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1159749000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-8770000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8770000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1150979000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,268191000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-168000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,882620000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,882620000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-860000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,883480000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,236400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.74
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,237200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.72
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,236300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.74
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2408044000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,103402000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2511446000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,302639000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,302639000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2208807000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,570436000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,417174000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,122431000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-53812000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1056229000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1152578000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-16290000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16290000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1136288000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,274774000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-5394000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,856120000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,856120000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-738000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,856858000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,236217000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.63
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,236972000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.62
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,236000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3,2014-07-01,2014-09-30,2015-10-21 16:17:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.63
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6807282000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,255367000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7062649000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,873771000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,873771000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6188878000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1658732000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1393331000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,382515000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-58351000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3376227000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2812651000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-17030000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17030000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2795621000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,721709000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-14932000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2058980000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2058980000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,7660000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2051320000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,236217000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,8.68
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,236972000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,8.65
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,236000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,8.68
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8683778000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,344721000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9028499000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1132324000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1132324000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7896175000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2181589000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1815564000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,491939000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-63494000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4425598000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3470577000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-22435000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22435000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3448142000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,911970000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-19886000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2516286000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2516286000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,7660000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2508626000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,236217000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,10.61
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,236972000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,10.56
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,236000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,10.61
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4399238000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,151965000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4551203000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,571132000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,571132000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3980071000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1088296000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,976157000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,260084000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-4539000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2319998000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1660073000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-740000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-740000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1659333000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,446935000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-9538000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1202860000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1202860000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,8398000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1194462000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,236661000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.05
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,237401000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.03
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,236600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.05
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8032498000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,312335000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8344833000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1064381000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1064381000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7280452000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2016737000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1808407000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,469506000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-16728000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4277922000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3002530000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10785000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10785000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2991745000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,823301000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-20662000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2147782000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2147782000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,8398000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2139384000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,236661000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,9.04
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,237401000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,8.99
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,236600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,9.04
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2359588000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,61864000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2421452000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,291887000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,291887000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2129565000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,576622000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,447273000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,116826000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,119000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1140840000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,988725000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4861000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4861000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,993586000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,268521000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-1933000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,723132000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,723132000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,8626000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,714506000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,236661000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.02
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,237401000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.01
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,236600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 16:25:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.02
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2039650000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,90101000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2129751000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,279245000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,279245000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1850506000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,511674000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,528884000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,143258000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-4658000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1179158000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,671348000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5601000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5601000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,665747000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,178414000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-7605000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,479728000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,479728000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-228000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,479956000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,236786000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.03
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,237849000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.02
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,236400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1,2014-01-01,2014-03-31,2014-04-23 13:24:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.03
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7347613000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,299241000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7646854000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1003222000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1003222000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6643632000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1871127000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1688597000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,434905000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-27329000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3967300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2676332000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-26074000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26074000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2650258000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,713920000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-21018000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1915320000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1915320000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-228000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1915548000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,236786000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,8.09
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,237849000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,8.04
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,236400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,8.09
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10527700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,236100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10763800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1240400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1240400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9523400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2113100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2012800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,382600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,93400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,30500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4632400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4891000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-123700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-123700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4767300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1161600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-12500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3593200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3593200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,46200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3547000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,230700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,15.38
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,231200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,15.34
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,230600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,FY,2015-01-01,2015-12-31,2018-02-01 16:35:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,15.38
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2759800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,79500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2839300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,331900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,331900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2507400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,583000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,541700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,96600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,93400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,24700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1339400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1168200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-82400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-82400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1085800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,257100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,828700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,828700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-2800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,831600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,230700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.78
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,231200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.77
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,230600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.78
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2728900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,49000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2777900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,310000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,310000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2467900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,477800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,519900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,98100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1096000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1371800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-15400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1356400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,330100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-6800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1019500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1019500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,53900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,965600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,232200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.16
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,232600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.15
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,232100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3,2015-07-01,2015-09-30,2016-10-26 16:16:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.16
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7767900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,156600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7924500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,908500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,908500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7016000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1530100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1471100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,286000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,5800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3293000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3722800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-41300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-41300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3681500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,904500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-12500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2764500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2764500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,49000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2715400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,232200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,11.6
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,232600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,11.57
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,232100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,11.6
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10359418000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,205733000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10565151000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1205729000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1205729000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9359422000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2103668000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1971169000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,393285000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,8451000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4476573000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4882549000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-50070000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-50070000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4832479000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1172691000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-12668000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3647120000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3647120000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,48140000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3598880000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,232200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,15.34
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,232600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,15.29
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,232100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,15.34
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2536100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,55600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2591700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,286100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,286100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2305600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,491900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,490700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,92000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-2200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1072400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1233100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1222200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,292500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-4900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,924800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,924800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-2500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,927300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,235300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.94
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,235700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.93
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,235400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2,2015-04-01,2015-06-30,2016-07-21 17:30:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.94
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5039000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,107600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5146600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,598500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,598500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4548100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1052300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,951200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,187900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,5600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2197000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2351000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-25900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-25900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2325100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,574400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-5700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1745000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1745000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-4900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1749800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,235300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,7.44
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,235700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,7.42
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,235400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.44
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10038562000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,260135000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10298697000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1198368000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1198368000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9100329000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2196304000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1868443000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,417616000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-45561000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4436802000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4663327000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-50960000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-50960000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4612367000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1117365000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-11262000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3483740000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3483740000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-6498000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3490138000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,235300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,14.81
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,235700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,14.76
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,235400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,14.81
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2502900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,52000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2554900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,312400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,312400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2242500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,560400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,460500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,95900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,7800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1124600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1117900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-15000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1102900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,281900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,820200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,820200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-2400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,822500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,235000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.5
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,235600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.49
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,235000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1,2015-01-01,2015-03-31,2016-04-21 16:57:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.5
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9862050000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,266399000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10128449000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1204155000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1204155000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8924294000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2281026000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1825016000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,442442000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-43242000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4505242000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4418952000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-35199000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-35199000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4383753000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1093386000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-8295000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3282072000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3282072000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,4628000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3277344000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,235000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,13.89
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,235600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,13.84
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,235000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,13.89
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11448800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11448800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1478700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1478700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9970100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1946600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1973300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,385600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,10200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,33100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,469600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4818400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5151700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-218700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-218700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4933000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1237300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3695700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3695700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-7100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3702800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,218400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,16.96
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,218800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,16.93
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,218300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 17:21:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,16.96
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3137500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-265500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2872000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,378500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,378500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2493500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,494200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,533900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,104200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,11100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,11800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,450800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1606000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,887500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-49300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-49300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,838200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,190300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,647900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,647900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,649200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,218400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.01
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,218800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,218300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.01
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2857200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,98600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2955800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,416900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,416900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2538900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,462700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,529000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,99700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,11600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,5900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1113600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1425300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-58100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-58100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1367200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,337000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1030200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1030200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-2700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1032900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,218900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.72
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.71
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,218800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 16:35:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.72
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8311300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,265500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8576800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1100200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1100200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7476600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1452400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1439400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,281400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,21300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,18800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3212400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4264200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-169400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-169400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4094800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1047000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3047800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3047800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-5800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3053600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,218900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,13.95
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,13.93
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,218800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,13.95
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11071100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,345000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11416100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1432100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1432100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9984000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2035400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1981100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,378000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,114700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,43500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4551800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5432400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-251800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-251800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5180600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1304100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3876500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3876500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-8600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3885200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,218900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,17.73
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,17.7
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,218800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,17.73
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2815200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,79000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2894200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,370300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,370300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2523900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,492400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,473100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,92900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-5600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,10600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1063400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1460500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-58500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-58500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1402000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,353600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1048400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1048400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1049800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,219100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.79
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.79
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,219200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2,2016-04-01,2016-06-30,2017-07-25 16:22:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.79
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5454100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,166900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5621000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,683300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,683300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4937700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,989700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,910400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,181700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-5600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,9700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,12900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2098800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2838900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-111300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-111300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2727600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,710000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2017600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2017600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-3100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2020700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,219100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,9.23
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,9.22
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,219200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,9.23
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10942800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,295400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11238200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1325200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1325200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9913000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2050500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1972000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,376400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-5600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,103100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,37800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4534200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5378900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-209100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-209100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5169800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1297200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-6800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3865800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3865800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,48000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3817900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,219100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,17.17
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,17.14
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,219200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,17.17
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2638900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,87900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2726800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,313000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,313000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2413800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,497300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,437300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,88800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,9700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,2300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1035400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1378400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-52800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-52800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1325600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,356400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,969200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,969200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,970900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,218900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.44
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.43
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,218700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1,2016-01-01,2016-03-31,2017-04-25 16:18:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.44
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10663700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,272000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10935700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1241000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1241000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9694700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2050000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1989600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,375500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,103100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,25000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4543200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5151500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-161500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-161500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4990000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1236100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-11700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3742200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3742200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,46900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3695400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,218900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,16.32
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,16.28
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,218700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,16.32
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12273900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12273900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1630000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1630000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10643900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1933900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2373600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,814700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,112300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,62700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5298100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5345800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-217000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-217000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5128800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2458700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2670100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2670100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,131000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2539100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,212600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,11.94
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,213000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,11.92
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,212700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,FY,2017-01-01,2017-12-31,2020-02-06 16:32:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,11.94
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3077800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3077800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,370000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,370000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2707800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,433400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,446400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,108900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,35200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,30000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1053900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1653900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-44000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-44000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1609900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,383800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1226100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1226100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1226100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,211400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.8
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,211800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.79
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,211400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3,2017-07-01,2017-09-30,2018-10-23 16:25:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.8
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8876900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,90000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8966900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1120800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1120800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7846100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1361900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1786000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,674900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,82500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,61200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3966500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3879600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-150600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-150600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3729000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,892600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2836400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2836400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2836500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,211400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,13.34
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,211800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,13.32
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,211400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,13.34
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12014400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-175500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11838900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1499300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1499300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10339600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1856100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2319900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,779100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,93600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,11800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,512000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5572500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4767100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-199900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-199900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4567200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1082900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3484300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3484300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3485700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,211400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,16.35
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,211800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,16.32
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,211400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,16.35
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3078400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3078400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,366200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,366200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2712200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,429800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,916200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,117500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,26500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,21200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1511200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1201000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-68600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-68600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1132400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,269600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,862800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,862800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,862800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,211900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.07
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,212200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.07
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,212000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2,2017-04-01,2017-06-30,2018-07-24 16:53:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.07
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5799100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,90000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5889100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,750800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,750800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5138300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,928500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1339600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,566000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,47300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,31200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2912600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2225700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-106600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-106600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2119100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,508800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1610300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1610300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1610400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,211900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,7.54
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,212200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,7.53
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,212000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.54
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11793800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-76900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11716900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1546200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1546200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10170700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1885400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2402500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,769900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,63100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,23400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,487900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5632200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4538500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-214000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-214000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4324500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1036100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3288400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3288400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-4100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3292500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,211900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,15.27
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,212200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,15.24
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,212000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,15.27
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2720700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,90000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2810700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,384600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,384600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2426100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,498700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,423400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,448500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,20800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,10000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1401400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1024700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-38000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-38000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,986700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,239200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,747500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,747500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,747600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,215600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.47
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,215900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.46
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,215400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 16:53:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.47
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11530600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,2100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11532700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1550300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1550300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9982400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1948000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1959400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,745300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,31000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,23400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,477300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5184400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4798000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-203900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-203900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4594100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1120100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3474000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3474000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-5500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3479500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,215600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,15.99
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,215900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,15.96
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,215400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,15.99
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13452900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13452900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1816300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1816300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11636600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2106300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2709700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,747300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,185000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,12000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-12300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5748000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5888600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,11000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5899600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1425600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4474000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4474000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,43300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4430700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,204900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,21.63
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,205300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,21.58
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,204800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,FY,2018-01-01,2018-12-31,2020-02-06 16:32:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,21.63
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3526300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3526300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,488500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,488500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3037800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,591100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,611600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,254100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,55800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,79300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1594700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1443100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-28600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-28600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1414500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,469600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,944900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,944900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,946800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,204900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.73
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,205300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.71
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,204800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.73
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3439000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3439000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,460800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,460800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2978200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,497700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,535400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,281900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,47500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,6000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-87900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1280600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1697600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,115100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,115100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1812700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,369800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1442900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1442900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1444400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,201400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,7.17
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,201900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,7.15
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,201500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3,2018-07-01,2018-09-30,2019-10-22 16:12:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.17
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9926600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9926600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1327800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1327800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8598800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1515200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2098100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,493200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,129200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,9200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-91600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4153300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4445500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,39600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,39600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4485100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,956000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3529100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3529100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,45200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3483900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,201400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,16.9
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,201900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,16.87
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,201500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,16.9
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13323600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-90000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13233600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1837000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1837000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11396600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2087200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2685700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,633000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,159000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,10100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-90100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5484900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5911700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-26800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5884900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2522100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3362800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3362800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,176300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3186500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,201400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,15.5
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,201900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,15.47
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,201500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,15.5
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3356500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3356500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,421000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,421000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2935500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,516200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1056000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,107400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,39200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1722300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1213200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-34500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-34500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1178700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,263700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,915000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,915000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,48400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,866600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,207100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.18
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,207300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.18
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,207300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2,2018-04-01,2018-06-30,2019-07-23 17:47:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.18
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6487600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6487600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,867000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,867000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5620600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1017500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1562700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,211300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,81700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-3700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2872700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2747900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-75500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-75500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2672400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,586200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2086200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2086200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,46700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2039500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,207100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,9.73
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,207300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,9.72
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,207300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,9.73
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12962400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-90000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12872400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1746200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1746200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11126200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2022900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2596700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,460000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,146700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,27800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5258200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5868000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-185900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-185900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5682100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2536100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3146000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3146000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,177800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2968200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,207100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,14.13
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,207300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,14.11
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,207300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,14.13
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3131100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3131100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,446000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,446000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2685100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,501300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,506700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,103900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,42500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-5600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1150400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1534700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-41000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-41000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1493700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,322500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1171200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1171200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1172900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,211400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.55
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,211700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.54
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,211300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1,2018-01-01,2018-03-31,2019-04-24 16:46:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.55
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12684300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-90000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12594300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1691400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1691400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10902900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1936500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2456900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,470100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,134000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,47100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5047100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5855800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-220000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-220000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5635800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2542000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3093800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3093800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,129400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2964400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,211400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,14.02
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,211700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,14.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,211300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,14.02
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14377900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14377900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1955400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1955400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12422500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2374700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2280600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,489900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,241600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-8400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5379900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7042600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,83300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,83300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7125900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1158000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-79400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5888500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5888500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5888500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,187100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,31.47
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,187400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,31.42
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,187100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,FY,2019-01-01,2019-12-31,2020-02-06 16:32:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,31.47
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3671300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3671300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,447100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,447100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3224200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,664900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,691700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,67700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-55700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,77900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1446500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1777700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-49300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-49300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1728400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,276100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-12600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1439700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1439700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1439700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,187100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,8.05
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,187400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,8.03
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,187100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,8.05
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10706600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10706600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1508300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1508300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9198300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1709800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1588900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,422200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,297300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-86300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3933400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5264900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,132600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,132600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5397500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,881900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-66800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4448800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4448800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4448800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,184000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,23.42
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,184200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,23.39
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,184000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,23.42
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14232900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14232900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1996800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1996800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12236100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2300900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2200500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,676300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,353100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-7000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5528100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6708000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,104000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,104000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6812000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1351500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-66800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5393700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5393700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5395600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,184000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,28.15
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,184200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,28.1
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,184000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,28.15
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3600100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3600100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,430000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,430000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3170100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,554500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,540400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,283900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,60200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-75500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1363800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1806300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-27300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-27300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1779000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,211300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-21800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1545900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1545900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1545900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,184000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,8.4
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,184200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,8.39
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,184000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q3,2019-07-01,2019-09-30,2019-10-22 16:12:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,8.4
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3616700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3616700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,476300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,476300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3140400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,587600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,484800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,70100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,63500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-22300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1184500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1955900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-197400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-197400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1758500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,248100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-16300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1494100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1494100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1494100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,190300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,7.85
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,190400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,7.85
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,190300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2,2019-04-01,2019-06-30,2019-07-23 17:47:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.85
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7106500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7106500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1078300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1078300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6028200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1155300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1048500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,138300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,237100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-10800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2569600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3458600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,159900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,159900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3618500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,670600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-45000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2902900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2902900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2902900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,190300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,15.02
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,190400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,15.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,190300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,15.02
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14071800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14071800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2027600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2027600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12044200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2244100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2195500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,674300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,340400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,10000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-19400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5444900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6599300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,246400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,246400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6845700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1510000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-45000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5290700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5290700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-3400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5294100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,190300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,26.92
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,190400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,26.86
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,190300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,26.92
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3489800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3489800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,602000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,602000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2887800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,567700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,563700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,68200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,173600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,11500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1385100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1502700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,357300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,357300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1860000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,422500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-28700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1408800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1408800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1408800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,196600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,7.17
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,197000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,7.15
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,196500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 16:15:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.17
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13811600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13811600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1972300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1972300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11839300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2172700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2766700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,711600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,316100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,10800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5982700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5856600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,409300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,409300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6265900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1525600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-28700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4711600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4711600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,45000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4666600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,196600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,23.25
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,197000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,23.19
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,196500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,23.25
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14422400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14422400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1807700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1807700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12614700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2377100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2268200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,493200000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,139800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-24500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5254900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7359800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-394500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-394500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6965300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1027500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-65500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5872300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5872300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-6500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5878800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,172800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,32.4
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,173100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,32.35
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,172700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,32.4
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3534300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3534300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,454300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,454300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3080000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,570100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,551300000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,71500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,71800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-4600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1260100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1819900000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-120500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-120500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1699400000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,292000000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-14800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1392600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1392600000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-6500000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1399100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,172800000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,8.1
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,173100000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,8.08
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,172700000.0
Biogen Inc,BIIB,W8J5WZB5IY3K0NDQT671,0000875045,2020.0,Q1,2020-01-01,2020-03-31,2020-04-23 16:15:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,8.1
